Survival and recurrence after intraperitoneal chemotherapy use: Retrospective review of ovarian cancer hospital registry data

BACKGROUND: Intraperitoneal/intravenous chemotherapy (IP/IV) was associated with improved survival for ovarian cancer (OC) patients in several randomized clinical trials. However, the uptake of IP/IV in clinical practice is varied due to conflicting evidence about its impact on survival and recurren...

Descripción completa

Detalles Bibliográficos
Autores principales: Adambekov, Shalkar, Lopa, Samia, Edwards, Robert P., Lemon, Lara, Wang, Shu, Taylor, Sarah E., Orr, Brian, Linkov, Faina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571805/
https://www.ncbi.nlm.nih.gov/pubmed/32813321
http://dx.doi.org/10.1002/cam4.3340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571805/
https://www.ncbi.nlm.nih.gov/pubmed/32813321
http://dx.doi.org/10.1002/cam4.3340

Ejemplares similares